Skip to Content

Vancenase AQ DS Side Effects

Generic Name: beclomethasone nasal

Note: This document contains side effect information about beclomethasone nasal. Some of the dosage forms listed on this page may not apply to the brand name Vancenase AQ DS.

For the Consumer

Applies to beclomethasone nasal: nasal aerosol liquid, nasal aerosol powder, nasal spray

Along with its needed effects, beclomethasone nasal (the active ingredient contained in Vancenase AQ DS) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking beclomethasone nasal:

More common

Less common

Incidence not known

  • Bloody mucus
  • cough or hoarseness
  • difficulty with breathing
  • dizziness
  • hives or welts, itching
  • loss of taste and smell
  • sores inside the nose

For Healthcare Professionals

Applies to beclomethasone nasal: nasal aerosol with adapter, nasal spray

General

The most commonly reported side effects were epistaxis, nasal discomfort, throat irritation, and headache.[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions (including anaphylaxis, angioedema, rash, urticaria, and bronchospasm)[Ref]

Respiratory

Common (1% to 10%): Epistaxis, nasal discomfort, sneezing attacks, nasal stuffiness, rhinorrhea
Frequency not reported: Nasal ulcerations, dryness and irritation of the nose and throat
Postmarketing reports: Nasal septal perforation
Rare (less than 0.1%): Wheezing[Ref]

Endocrine

Frequency not reported: Hypercorticism, adrenal suppression, growth reduction in children[Ref]

Gastrointestinal

Common (1% to 10%): Nausea[Ref]

Nervous system

Common (1% to 10%): Headache, lightheadedness
Postmarketing reports: Loss of taste and smell, unpleasant taste and smell[Ref]

Immunologic

Frequency not reported: Candida albicans infection, immunosuppression[Ref]

Ocular

Common (1% to 10%): Tearing eyes
Postmarketing reports: Glaucoma, cataracts
Rare (less than 0.1%): Increased intraocular pressure[Ref]

Other

Frequency not reported: Impaired wound healing[Ref]

References

1. "Product Information. Qnasl (beclomethasone nasal)." Teva Pharmaceuticals USA, North Wales, PA.

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

4. "Product Information. Beconase AQ (beclomethasone nasal)." GlaxoSmithKline, Research Triangle Park, NC.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide